Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of Ophthalmology Times.
SOE 2023: New dehydrated human amniotic membrane promotes healing of the ocular surface
June 15th 2023Omnigen® may be an alternative treatment option for patients with a persistent corneal epithelial defect. The product provides a convenient and effective treatment that can be administered in an outpatient setting.
Read More
BEHOLD Trial: UBX1325, a potential new therapeutic option for treating diabetic macular edema
June 12th 2023Senescent cells accumulate in areas of disease activity in DME and wet age-related macular degeneration and release mediators that drive the pathology. UBX1325 seems to prevent that disease activity.
Read More
The European Society of Ophthalmology's (SOE) focus on young ophthalmologists
June 1st 2023SOE holds a special place in its heart for the up-and-coming young ophthalmologists and is providing them a number of opportunities to hone their skills and establish professional contacts at this meeting.
Read More
ARVO 2023: Association between visual impairment and neuropsychiatric symptoms of dementia
April 24th 2023Researchers found in their analysis that visual impairment is associated with hallucinations, depression, agitation, and psychosis in patients with dementia, although, aging and comorbidities, among other factors, may be involved.
Read More
ARVO 2023: Ocular blood flow and its relationship to acute coronary syndrome
April 24th 2023The team of Japanese researchers found that the choroidal MBR in the nasal region is correlated with systemic arterial stiffness and is significantly lower in patients with coronary artery multivessel disease.
Read More
Visual acuity outcomes after repair of uncomplicated rhegmatogenous retinal detachments
April 18th 2023Dr Ong and colleagues undertook a retrospective study of patients who underwent primary repair of uncomplicated RRDs at the Wilmer Eye Institute to examine the baseline, surgical, and postoperative characteristics that affect best-corrected VA (BCVA) outcomes.
Read More
Decreased cone densities may help detect and monitor multiple sclerosis
April 13th 2023Decreased cone density was a characteristic of the cases of multiple sclerosis (MS) that were evaluated. This finding may serve as a specific and sensitive method to detect and monitor the development and progression of MS.
Read More
Crystalline lens power: The primary driver of the refractive error in ROP eyes treated with laser
April 13th 2023The study compared eyes with retinopathy of prematurity (ROP) treated with laser to age-matched control eyes without ROP and found that the spherical equivalent was significantly more myopic in the eyes treated with laser.
Read More
ARVO 2023: Opportunities to enjoy social/networking events
April 13th 2023The 2023 Association for Research in Vision and Ophthalmology (ARVO) annual meeting promises to provide numerous opportunities to meet up with old friends and colleagues and forge relationships with new ones as well as enhance future research and practice endeavors.
Read More
ARVO 2023: Celebrating the beauty of diversity in science and nature
April 12th 2023The Association for Research in Vision and Ophthalmology (ARVO) 2023 annual meeting is convening in New Orleans from April 23 to 27 at the Ernest N. Morial Convention Center. The theme of the Annual Meeting speaks both to the mechanistic diversity in ocular disease in addition to the diversity of vision scientists who are from multiple backgrounds and perspectives.
Read More
COPHy 2023: New restorative therapies
March 24th 2023In a keynote lecture at the 14th Annual Congress on Controversies in Ophthalmology in Lisbon, Hendrik Scholl, MD, co-founder and director of the Institute of Molecular and Clinical Ophthalmology Basel, discussed its mission to unravel the mysteries of vision and human eye disease.
Read More